Sanofi (SNYNF) Liabilities and Shareholders Equity (2009 - 2025)

Sanofi (SNYNF) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $149.9 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 8.04% year-over-year to $149.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $590.7 billion (up 40.51% YoY) and the FY2025 annual result came in at $147.6 billion, up 4.02% from the prior year.
• Liabilities and Shareholders Equity rose to $149.9 billion in Q1 2026 per SNYNF's latest filing, from $147.6 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $151.7 billion in Q3 2025, with the low at $129.3 billion in Q4 2022.
• Average Liabilities and Shareholders Equity over 5 years is $140.3 billion, with a median of $139.7 billion recorded in 2024.
• Year-over-year, Liabilities and Shareholders Equity dropped 6.01% in 2022 and gained 8.04% in 2026.
• Sanofi's Liabilities and Shareholders Equity stood at $129.3 billion in 2022, then rose by 5.24% to $136.1 billion in 2023, then rose by 4.29% to $141.9 billion in 2024, then gained by 4.02% to $147.6 billion in 2025, then advanced by 1.54% to $149.9 billion in 2026.
• Business Quant data shows SNYNF's Liabilities and Shareholders Equity at $149.9 billion in Q1 2026, $147.6 billion in Q4 2025, and $151.7 billion in Q3 2025.